TransMedics Group Inc (TMDX)
Gross profit margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Gross profit | US$ in thousands | 262,081 | 154,093 | 65,272 | 21,159 | 16,635 |
Revenue | US$ in thousands | 441,540 | 241,623 | 93,459 | 30,262 | 25,639 |
Gross profit margin | 59.36% | 63.77% | 69.84% | 69.92% | 64.88% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $262,081K ÷ $441,540K
= 59.36%
The gross profit margin of TransMedics Group Inc has shown fluctuation over the years based on the provided data. It increased from 64.88% as of December 31, 2020, to 69.92% by December 31, 2021, reflecting an improvement in the company's ability to generate profit from its core business activities. However, there was a slight decrease in the gross profit margin to 69.84% by December 31, 2022, which indicates a potential stabilization or slight adjustment in profitability.
Subsequently, the gross profit margin experienced a more notable decline to 63.77% by December 31, 2023, suggesting a decrease in the efficiency of the company's production and/or pricing strategies. This trend continued with a further decrease to 59.36% by December 31, 2024, indicating a substantial reduction in the profitability of TransMedics Group Inc.
Overall, the analysis of the gross profit margin highlights both positive and negative trends in the company's ability to generate profit from its core operations. It is essential for stakeholders to closely monitor these fluctuations and identify potential factors driving these changes to make informed decisions regarding the company's financial performance and future prospects.
Peer comparison
Dec 31, 2024